Search Results - "Ertl, H. C."

Refine Results
  1. 1

    Adenovirus-Based Vaccines: Comparison of Vectors from Three Species of Adenoviridae by CHEN, H, XIANG, Z. Q, SERWANGA, J, AUMA, B, KALEEBU, P, ZHOU, X, BETTS, M. R, ERTL, H. C. J, LI, Y, KURUPATI, R. K, JIA, B, BIAN, A, ZHOU, D. M, HUTNICK, N, YUAN, S, GRAY, C

    Published in Journal of Virology (01-10-2010)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  2. 2

    CD4+ and CD8+ T-Cell Responses to Latent Antigen EBNA-1 and Lytic Antigen BZLF-1 during Persistent Lymphocryptovirus Infection of Rhesus Macaques by Leskowitz, R M, Zhou, X Y, Villinger, F, Fogg, M H, Kaur, A, Lieberman, P M, Wang, F, Ertl, H C

    Published in Journal of Virology (01-08-2013)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  3. 3

    Chimpanzee-origin adenovirus vectors as vaccine carriers by TATSIS, N, TESEMA, L, ROBINSON, E. R, GILES-DAVIS, W, MCCOY, K, GAO, G. P, WILSON, J. M, ERTL, H. C. J

    Published in Gene therapy (01-03-2006)
    “…Vaccines based on replication-defective adenoviral vectors are being developed for infectious agents and tumor-associated antigens. Early work focused on…”
    Get full text
    Journal Article
  4. 4

    Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut by Lin, S.W, Cun, A.S, Harris-McCoy, K, Ertl, H.C

    Published in Vaccine (08-03-2007)
    “…Abstract Gut-associated lymphoid tissue (GALT) is the primary replication site for HIV-1, resulting in a pronounced CD4+ T cell loss in this tissue during…”
    Get full text
    Journal Article
  5. 5

    Human Immunodeficiency Virus Type 1-Specific Immune Responses in Primates upon Sequential Immunization with Adenoviral Vaccine Carriers of Human and Simian Serotypes by REYES-SANDOVAL, A, FITZGERALD, J. C, GRANT, R, ROY, S, XIANG, Z. Q, LI, Y, GAO, G. P, WILSON, J. M, ERTL, H. C. J

    Published in Journal of Virology (01-07-2004)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  6. 6

    Immune responses to DNA vaccines by Kowalczyk, D. W, Ertl, H. C. J

    “…DNA vaccines, based on plasmid vectors expressing an antigen under the control of a strong promoter, have been shown to induce protective immune responses to a…”
    Get full text
    Journal Article
  7. 7

    Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier by Xiang, Z. Q., Gao, G. P., Reyes-Sandoval, A., Li, Y., Wilson, J. M., Ertl, H. C. J.

    Published in Journal of Virology (01-10-2003)
    “…Erratum ( vol. 79 , p. 3888 ) Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious…”
    Get full text
    Journal Article
  8. 8

    Human immune responses to traditional and novel rabies vaccines by Ertl, H C J

    “…Traditional rabies vaccines given preventatively or after exposure to the virus induce cluster of differentiation 4+ (CD4+) T cell responses that promote the…”
    Get full text
    Journal Article
  9. 9

    Protection of non-human primates against rabies with an adenovirus recombinant vaccine by Xiang, Z.Q, Greenberg, L, Ertl, H.C, Rupprecht, C.E

    Published in Virology (New York, N.Y.) (01-02-2014)
    “…Abstract Rabies remains a major neglected global zoonosis. New vaccine strategies are needed for human rabies prophylaxis. A single intramuscular immunization…”
    Get full text
    Journal Article
  10. 10

    Adenovirus-mediated artificial MicroRNAs targeting matrix or nucleoprotein genes protect mice against lethal influenza virus challenge by Zhang, H, Tang, X, Zhu, C, Song, Y, Yin, J, Xu, J, Ertl, H C J, Zhou, D

    Published in Gene therapy (01-08-2015)
    “…Influenza virus (IV) infection is a major public health problem, causing millions of cases of severe illness and as many as 500 000 deaths each year worldwide…”
    Get full text
    Journal Article
  11. 11

    Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection by Jeyanathan, M, Thanthrige-Don, N, Afkhami, S, Lai, R, Damjanovic, D, Zganiacz, A, Feng, X, Yao, X-D, Rosenthal, K L, Fe Medina, M, Gauldie, J, Ertl, H C, Xing, Z

    Published in Mucosal immunology (01-11-2015)
    “…Pulmonary tuberculosis (TB) remains to be a major global health problem despite many decades of parenteral use of Bacillus Calmette–Guérin (BCG) vaccine…”
    Get full text
    Journal Article
  12. 12

    Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques by Leskowitz, R, Fogg, M H, Zhou, X Y, Kaur, A, Silveira, E L V, Villinger, F, Lieberman, P M, Wang, F, Ertl, H C

    Published in Journal of virology (01-05-2014)
    “…The impact of Epstein-Barr virus (EBV) on human health is substantial, but vaccines that prevent primary EBV infections or treat EBV-associated diseases are…”
    Get full text
    Journal Article
  13. 13

    The effect of CpG sequences on the B cell response to a viral glycoprotein encoded by a plasmid vector by Pasquini, S, Deng, H, Reddy, S T, Giles-Davis, W, Ertl, H C

    Published in Gene therapy (01-08-1999)
    “…The effect of palindromic CpG sequences on the B cell response to plasmid vectors expressing a highly immunogenic viral glycoprotein was investigated…”
    Get full text
    Journal Article
  14. 14

    An Experimental Vaccine Expressing Wild‐Type p53 Induces Protective Immunity against Glioblastoma Cells with High Levels of Endogenous p53 by BLASZCZYK‐THURIN, M., O, I., ERTL, H. C. J.

    Published in Scandinavian journal of immunology (01-10-2002)
    “…Inoculation of mice with a recombinant vaccinia virus expressing the full‐length mouse wild‐type p53 protein (Vp53‐wt) was shown to induce partial protection…”
    Get full text
    Journal Article
  15. 15

    Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses by Yang, Y, Li, Q, Ertl, H C, Wilson, J M

    Published in Journal of Virology (01-04-1995)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  16. 16

    P16-09. Adenovirus 5 vector HIV vaccination does not affect mucosal homing markers on Ad5-specific CD4+ T-cells in humans by Hutnick, N, Carnathan, D, Dubey, S, Cox, K, Ratcliffe, S, Robertson, MN, Casimiro, DR, Ertl, HC, Betts, MR

    Published in Retrovirology (22-10-2009)
    “…Conclusion This data suggests that vaccination does not induce a differential measurable effect on mucosal trafficking in circulating Ad-specific CD4+ T cells…”
    Get full text
    Journal Article
  17. 17

    Influenza Virus Specific CD8+ T Cells Exacerbate Infection Following High Dose Influenza Challenge of Aged Mice by Ertl, H. C., Wherry, E. J., Manson, B., Kannan, S., Small, J. C., Latimer, B. P., DiMenna, L. J., Parzych, E. M., Lasaro, M. O.

    Published in BioMed research international (01-01-2013)
    “…Influenza viruses cause severe illnesses and death, mainly in the aged population. Protection afforded by licensed vaccines through subtype-specific…”
    Get full text
    Journal Article
  18. 18

    Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo by Yang, Y, Jooss, K U, Su, Q, Ertl, H C, Wilson, J M

    Published in Gene therapy (01-02-1996)
    “…Human adenoviruses have been developed as an attractive vehicle for in vivo liver-directed gene therapy. Problems with the application of first generation…”
    Get more information
    Journal Article
  19. 19

    T Helper Cell-Independent Antibody Responses to the Transgene Product of an E1-Deleted Adenoviral Vaccine Require NK1.1 T Cells by Xiang, Z.Q., Gao, G.P., Li, Y., Wilson, J.M., Ertl, H.CJ

    Published in Virology (New York, N.Y.) (20-01-2003)
    “…Mice lacking CD4+ T cells due to a knock-out mutation respond to vaccination with a replication-defective adenoviral recombinant expressing the glycoprotein of…”
    Get full text
    Journal Article
  20. 20

    Upregulation of Class I Major Histocompatibility Complex Antigens by Interferon γ is Necessary for T-Cell-Mediated Elimination of Recombinant Adenovirus-Infected Hepatocytes in vivo by Yang, Yiping, Xiang, Zhiquan, Hildegund C. J. Ertl, Wilson, James M.

    “…Recombinant adenoviruses are attractive vehicles for liver-directed gene therapy because of the high efficiency with which they transfer genes to hepatocytes…”
    Get full text
    Journal Article